Science Explorer Back to mapMap
Discussion
Researcher · Institutul Regional de Oncologie · Romania

Mihaela Zlei

Mihaela Zlei publishes mostly in Hematology, Immunology and Infectious Diseases, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Acute Lymphoblastic Leukemia research.

ORCID 0000-0002-6865-8883 OpenAlex
World rank
#5,614,670
of 7,710,434 ranked researchers
Rank in Romania
#13,868
of 26,789
Works
61
Citations
424
Citations per work
7.0
h-index
11
i10-index 13Top 54% in Hematology
Mihaela Zlei

What does Mihaela Zlei research?

Mihaela Zlei's work is mostly in Medicine (37%), Immunology and Microbiology (13%), Biochemistry, Genetics and Molecular Biology (6%).

Everything else: 27 works · 44.0% of their workHealth Sciences: 23 works · 37.3% of their workMedicine: 23 works · 37.3% of their workHematology: 9 works · 14.5% of their workInfectious Diseases: 5 works · 8.4% of their workGenetics: 4 works · 7.2% of their workPublic Health, Environmental and Occupational Health: 4 works · 7.2% of their workLife Sciences: 11 works · 18.7% of their workImmunology and Microbiology: 8 works · 12.7% of their workImmunology: 8 works · 12.7% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.0% of their workMolecular Biology: 4 works · 6.0% of their workTHEIR WORKMihaela Zlei61works
Life Sciences19%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2744.0%
    1. Medicine2337.3%
    1. Immunology and Microbiology812.7%
    2. Biochemistry, Genetics and Molecular Biology46.0%
  1. 1Hematology14% of their works
  2. 2Immunology13% of their works
  3. 3Infectious Diseases8% of their works
  4. 4Public Health, Environmental and Occupational Health7% of their works
  5. 5Genetics7% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe Mihaela Zlei's research?

The keywords of their largest research topics: Prognostic Factors, Minimal Residual Disease, ACE2 Receptor, SARS-CoV-2, Acute Myeloid Leukemia, AML, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors273 topics
  2. Minimal Residual Disease152 topics
  3. ACE2 Receptor122 topics
  4. SARS-CoV-2122 topics
  5. AML101 topic
  6. Acute Myeloid Leukemia101 topic
  7. Chronic Lymphocytic Leukemia91 topic
  8. Genomic Aberrations91 topic
  9. Acute Lymphoblastic Leukemia81 topic
  10. Childhood Cancer81 topic
  11. Coronavirus71 topic
  12. Diagnosis Criteria71 topic
  13. International Myeloma Working Group71 topic
  14. Vaccine71 topic
  15. Fc Receptors61 topic
  16. Foxp361 topic
  17. TGF-ß61 topic
  18. Therapeutic Antibodies61 topic
  19. Clinical Characteristics51 topic
  20. Epidemiology51 topic

Where does Mihaela Zlei work?

Mihaela Zlei's main affiliation in the publication record is Institutul Regional de Oncologie, Romania.

How many publications and citations does Mihaela Zlei have?

OpenAlex counts 61 works and 424 citations for Mihaela Zlei, an h-index of 11, ranking #5,614,670 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mihaela Zlei. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.